Growth peptide blend (GHRH + secretagogue)
Reconstitute a CJC-1295 / Ipamorelin blend and convert your dose into the exact units to draw. Pick your blend vial and bacteriostatic water volume, set your dose, and see the precise mark on a U-100 insulin syringe plus how much of each peptide you are drawing.
Draw to
Draw to the 6 unit mark. That is 0.060 mL of solution.
Informational and educational only. Not medical advice. This tool performs math on values you enter and is not a substitute for your prescriber.
It is a single vial holding two research peptides: CJC-1295, a GHRH analogue (usually the no-DAC modified GRF 1-29 form), and Ipamorelin, a selective growth hormone secretagogue. It is sold most often as a 1:1 blend, such as 5 mg of each peptide. The two are reconstituted together in one volume of bacteriostatic water, so each draw delivers both. Neither peptide is FDA-approved for human use.
It depends on your water volume. With a 5 mg / 5 mg vial in 2 mL of bacteriostatic water (2.5 mg/mL of each peptide), a 100 mcg dose is 0.04 mL, which is 4 units on a U-100 insulin syringe, delivering 100 mcg of each peptide. With the same vial in 1 mL (5 mg/mL), 100 mcg is 0.02 mL, or 2 units. Enter your own vial and water volume above for your exact number.
No. Both CJC-1295 and Ipamorelin are research peptides and are not approved by the FDA for human use. This tool does not recommend any dose or endorse any use. It only converts a dose you have been given into the units to draw. Consult a licensed clinician before using any peptide.
Both peptides at once. Because they share one vial and one solution, the volume you draw contains each peptide in proportion to its amount in the vial. With a 1:1 blend (equal milligrams of each), a draw delivers an equal dose of both. The breakdown next to the syringe above shows the exact amount of CJC-1295 and Ipamorelin your dose delivers.
Source: Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. · How we calculate